Navigation Links
Allos in Medical News

Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non-Urban Markets

...n approximately 600 companies in 30 countries. The firm has invested more than $6.5 billion in healthcare companies, including investments in allos Therapeutics, American Medical Systems, Bausch & Lomb, Coventry Health Care, Eurand, Euromedic International (acquired by Merrill Lynch Global Pri...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) allos THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq:...

Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing

...iversity, Long Beach. "I am very excited to join allos and lead the Company's manufacturing activities," said Mr. Bennett. "I believe allos has the product candidates and leadership team to ...ew therapies for the treatment of cancer." About allos Therapeutics, Inc. ...

Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference

...ch will be accessible through a link posted on the allos website home page and investor relations section. ... Allos' website through December 28, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focuse...

Allos Therapeutics Reports Third Quarter 2007 Financial Results

...al 480-629-9562. Participants should reference the allos Therapeutics conference call. Conference Call Rep...llos.com and will be archived for 30 days. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...

Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference

...be available for replay on Allos' website through November 20, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...
Allos in Medical Technology

Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma

WESTMINSTER, Colo., Dec. 27 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ) today announced that an independent Data Monitoring Committee (DMC) has completed the pre-specified 65-patient safety review of data from the Company's pivotal Phase 2 PROPEL trial of PDX (pralatrex...

Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma

PROPEL Enrollment Ahead of Schedule with Completion Expected Q2 2008 WESTMINSTER, Colo., Sept. 24 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ) today announced the completion of pre-planned interim analyses of patient response and safety data from the Company's pivotal ...

William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman

...at Sofinnova Ventures and serves as Chairman of the Board of Directors at Intermune and a member of the Board of Directors of Inspire Pharmaceuticals, allos Therapeutics, Alvine Pharmaceuticals, Portola Pharmaceuticals, and BioCrossroads, a not for profit organization. Mr. Ringo holds a B.S. and an M.B.A. ...

Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma

...mphoma represents approximately 10 percent. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...resentation, except as required by law. Note: The allos logo is a trademark of...

BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer

...t PARP-1 (poly-ADP-ribose polymerase), an enzyme crucial to cell repair and upregulated in certain tumors. Mr. Malek joins BiPar after seven years at allos Therapeutics where, as vice president of corporate development, he played a pivotal role in shifting Allos' strategy to focus solely on oncology asset...

Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma

...otrexate and certain other DHFR inhibitors. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focuse...resentation, except as required by law. Note: The allos logo is a trademark of...

Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission

...irst-line or relapsed or refractory PTCLs. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...pt as required by law. Note: EFAPROXYNTM and the allos logo are trademarks of Allos Therapeutics, Inc. ...

Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer

...1-689-8567. Call participants should reference the allos Therapeutics conference call. Conference Call Re...los.com and will be archived for 30 days. About allos allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...
Allos in Medical Definition

Allopathic medicine

...the symptoms. Often contrasted with homeopathy." [2] Other sources define allopathic medicine more in accord with the meaning of its word parts, allos meaning opposite and path meaning disease . Steadman's Medical Dictionary calls it a "therapeutic system in which a disease is treated by prod...
Allos in Biological Technology

OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development

...ale of that company to Sanofi-Aventis in April of this year. Previously, he held senior corporate development, marketing, and strategy positions with allos Therapeutics, Connetics Corporation, Abgenix and Gilead Sciences. Mr. Patel also served as a consultant with McKinsey & Company. Earlier in his ...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...SDAQ: ALXN ) ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) allos THERAPEUTICS INC. (NASDAQ: ALTH ) ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ...TM) Emerging Cancer Index (HHJ) Drop AETERNA ZENTARIS INC. (TSE: AEXS) allos THERAPEUTICS INC. (NASDAQ: ALTH ) ARQULE INC. (NASDAQ: ARQL ) ARRAY BIO...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...tics Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) allos THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: A...

Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

...e available for replay on Allos' website through February 22, 2008. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...

Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference

...be available for replay on Allos' website through November 27, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...

Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference

...s referenced above are available for review on the allos website (http://www.allos.com ) under the "Presen...Investor Relations" section of the website. About allos Therapeutics, Inc. allos Therapeutics, Inc. (ALTH) is a biopharmaceutical c...

Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference

... be available for replay on Allos' website through October 12, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...

Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference

...e available for replay on Allos' website through September 21, 2007. About allos Therapeutics, Inc. allos Therapeutics is a biopharmaceutical company focused on the development and ...
Other Tags
(Date:9/1/2015)... ... September 01, 2015 , ... Horizon Blue Cross Blue Shield of New Jersey ... in the LATINA Style 50 Report that recognizes companies that provide the best career ... Horizon BCBSNJ climbs from number 24 to 21 of the 50 Best Companies for ...
(Date:9/1/2015)... Eagan, Minnesota (PRWEB) , ... September 01, 2015 ... ... covered health care delivery options, Blue Cross and Blue Shield of Minnesota (Blue ... starting in 2016. , Based in San Francisco, Doctor On Demand provides ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in Houston, TX ... , an innovative vaginal health laser procedure that prevents and resolves dryness in ... atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful intercourse and ...
(Date:9/1/2015)... Burlington, MA (PRWEB) , ... September 01, 2015 ... ... for remote real-time monitoring and analysis of pet vital signs and activity, today ... Cornerstone is one of the most popular and widely-adopted veterinary hospital Practice Management ...
(Date:9/1/2015)... ... ... Royal River Natural Foods, a locally-owned independent natural health store in Freeport, ... and found that, among those who had a stroke, people who used multivitamins survived ... the September 2015 issue of “Natural Insights for Well Being,” which Royal River Natural ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 Research ... of the "Saudi Arabia Biomedical Sensors Market - ... offering. The Saudi Arabia Biomedical Sensors ... a CAGR of 3.64% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/24/2015)... The consulting company Frost & Sullivan ... DERMALOG and its customized solutions and products for ... the Year Award". DERMALOG is particularly successful with a large ... -Cross reference: Picture is available at AP Images ( ... Thursday evening, in South Africa,s economic ...
(Date:8/20/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market and creator of ... Smart Card Alliance and the EMV Migration Forum.  ... Smart Card Alliance Latin America (SCALA) Chapter provides NXT-ID, ... thought leaders promoting adoption of smart card technology. ...
Breaking Biology News(10 mins):Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4
Other Contents